Clinical trial

Vildagliptin Versus Dapagliflozin on Glucagon

NCT02475070

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-01-01

PhasePHASE4

Study timeline

Study start (unknown)2016-01-01Date precision: month

Registry last updated2019-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

VildagliptinDRUG

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

Sponsors & collaborators

Lund Universitylead sponsor

Mapped research locations

LundSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02475070 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.